Media OutReach
TruGlow Medical Aesthetics to Relocate to The Heeren Orchard in June 2026
A new centrally located clinic designed to enhance patient comfort and accessibility
SINGAPORE – Media OutReach Newswire – 2 June 2026 – TruGlow Medical Aesthetics announces its upcoming relocation to a new clinic space at The Heeren, one of Orchard Road’s most recognisable lifestyle destinations. The new clinic, located at 260 Orchard Road, #04-12 The Heeren, Singapore 238855, is scheduled to open on 02 June 2026. Situated along Orchard Road and within proximity to MRT stations and bus stops, the new location offers greater convenience for both existing and new patients.
A Thoughtful Step Forward for the Clinic
The new clinic space has been designed with patient comfort and discretion in mind, featuring a larger layout, enhanced privacy, upgraded consultation areas, and improved treatment room facilities. With this move, TruGlow aims to continue delivering care in a setting that reflects its emphasis on discretion, consistency, and professional standards, while supporting the clinic’s next phase of growth.
TruGlow aims to continue delivering care in a setting that aligns with its emphasis on discretion, consistency, and professional standards, while preparing the clinic for its next phase of growth.
A Clinic Environment Designed Around Patient Care
The new space has been planned to support a smoother experience from consultation to follow-up care, with upgraded treatment rooms and consultation spaces. This enables the clinical team to deliver care more efficiently and comfortably, without altering TruGlow’s established care philosophy.
While the physical space has evolved, the clinic’s commitment to careful assessment, appropriate recommendations, and evidence-based treatments remains unchanged.
Clinical Expertise Across Face, Eyes, and Body Concerns
TruGlow Medical Aesthetics is known for its experience in managing a range of commonly requested aesthetic concerns. The clinic is frequently consulted for undereye and eye bag treatments, where factors such as puffiness, volume changes, and skin quality are assessed holistically to guide suitable non-surgical approaches.
In addition, TruGlow provides care for back acne management, developing treatment plans that focus on skin clarity, comfort, and gradual improvement over time. These areas reflect the clinic’s emphasis on addressing both facial and body concerns through individualised assessment.
Advanced Non-Invasive Technologies Supporting Treatment Plans
To support its clinical recommendations, TruGlow offers a selection of non-invasive aesthetic technologies. These include Ultraformer MPT, which uses micro- and macro-focused ultrasound to address skin laxity and contour definition at different depths.
The clinic also provides Oligio, a monopolar radiofrequency treatment designed to support collagen remodelling and improve skin firmness, including areas that require more delicate handling such as around the eyes. As aesthetic technologies continue to evolve worldwide, TruGlow remains attentive to developments that may further enhance patient care in the future.
Looking Ahead at The Heeren
With its upcoming opening at The Heeren, TruGlow Medical Aesthetics looks forward to welcoming patients into a refreshed clinical environment while continuing to deliver the same medically guided, patient-centred care it is known for.
New address:
260 Orchard Road, #04-12 The Heeren
Singapore 238855
Opening: 02 June 2026
Hashtag: #SingaporeAesthetics #MedicalAestheticClinic #GlowWithConfidence #medicalaesthetics #UltraformerMPT #Oligio #EyeBagTreatment #UndereyeTreatment #BackAcneTreatment #SkinFirming #SkinRejuvenation
https://www.truglowaesthetics.com.sg/
https://linkedin.com/company/t-medical-aesthetics-pte-ltd-truglow-aesthetics
https://www.facebook.com/truglow.aesthetics
https://www.instagram.com/Truglow_MedicalAesthetics/
The issuer is solely responsible for the content of this announcement.
TruGlow Medical Aesthetics
At TruGlow Medical Aesthetics, we celebrate the transformative power of authenticity and the radiant glow that emanates from within. Our name, a harmonious blend of “True” and “Glow,” reflects our unwavering commitment to enhancing your genuine beauty and fostering a luminous, healthy appearance.
For more information, visit us at https://www.truglowaesthetics.com.sg/
Through DaaS, enterprise customers can access drone equipment, trained personnel, mission execution, data collection and project deliverables without purchasing and maintaining a complete in-house drone system. The model extends ZenaTech’s business beyond equipment sales and enables the company to generate recurring service revenue from customers’ operational requirements.
ZenaTech reported revenue of CAD 8.4 million for the first quarter of 2026, an increase of 640% from CAD 1.13 million in the same period of 2025. DaaS contributed approximately CAD 7.8 million, accounting for around 93% of quarterly revenue.
In 2025, the company generated annual revenue of CAD 12.9 million, up 558% from approximately CAD 2 million in 2024. DaaS contributed approximately CAD 10.1 million during its first full year of operations, representing around 78% of total annual revenue.
Acquisitions Support Service Network Expansion
ZenaTech has expanded its DaaS operations through a combination of internal technology development and acquisitions. The acquired businesses bring existing customers, professional teams and local operating capabilities, while ZenaTech gradually introduces drones, automated data collection and AI-supported analytics into selected workflows.
In 2025, the company completed 20 acquisitions, including 19 businesses providing engineering data, facility inspection and related professional services, as well as one enterprise software company.
By June 2026, ZenaTech had completed its 24th DaaS-related acquisition and expanded its services into property cleaning, facility inspection and maintenance.
Through its ZenaDrone subsidiary, ZenaTech has also developed drone products for indoor and outdoor operations. The IQ Quad supports site data collection, engineering imagery and 3D modelling, while the IQ Nano uses barcode and RFID scanning to support inventory records, shelf inspections and indoor data collection.
The company’s reported revenue growth, acquisition activity and DaaS contribution provide investors following the AI and drone sectors with measurable indicators of how its technologies are being integrated into commercial operations and converted into service revenue.
Hashtag: #ZenaTech
The issuer is solely responsible for the content of this announcement.
About ZenaTech
ZenaTech (Nasdaq: ZENA) is a technology company specialising in AI-powered drones, Drone-as-a-Service (DaaS), enterprise SaaS solutions and related technologies. Through its ZenaDrone subsidiary, the company develops drone products and software for commercial applications including engineering data collection, agriculture, warehouse management, facility inspection and property maintenance. ZenaTech combines its technology capabilities with a growing professional service network to support the adoption of drone-based solutions across a range of operational environments.
Media OutReach
A Defining Milestone for Gene Solutions: SPOT-MAS Multi-Cancer Screening Test Receives U.S. FDA Breakthrough Device Designation
The proposed indications for use describe SPOT-MAS 10 as a qualitative in vitro diagnostic test performed on plasma derived from a single direct-draw venous whole blood specimen. The test analyzes circulating cell-free DNA methylation and fragmentomic signatures using a machine-learning-based algorithm to detect a cancer-associated signal. It is intended for use as an adjunctive screening test in asymptomatic adults aged 40 years and older to assist in detecting cancers within the scope of the assay. These include five common cancers — breast, lung, liver, colorectal and gastric cancers — and five aggressive, less common cancers that currently lack standard screening methods — ovarian, pancreatic, esophageal, endometrial and head & neck cancers.
SPOT-MAS has been developed through years of rigorous scientific research and clinical development. In March 2025, SPOT-MAS became the first multi-cancer screening blood test in Asia to complete a large prospective cohort validation, with the K-DETEK study evaluating more than 9,000 asymptomatic participants and demonstrating strong performance, including high specificity and the ability to identify cancer-associated signals across multiple cancer types.
Since then, SPOT-MAS has been used in more than 100,000 individuals in real-world practice, with consistent performance observed beyond controlled study settings. Real-world data were presented at ESMO Asia 2025 and were featured at ASCO Breakthrough 2026 in Singapore.
The platform is built on a multi-omic approach— integrating genetics, epigenetics, and fragmentomics — together with AI-driven analysis, large-scale prospective validation, growing real-world evidence and focus on cancer types with high clinical relevance in the regions where the test is deployed.
For the United States, Breakthrough Device Designation provides Gene Solutions with a prioritized channel of engagement with the FDA as the company advances its U.S. development and validation plans.
Looking ahead, Gene Solutions will continue to collaborate with academic, clinical, laboratory, commercial and strategic partners to support responsible adoption of SPOT-MAS in accordance with local regulations, clinical guidelines and best practices.
Important Regulatory Notice: SPOT-MAS 10 has received U.S. FDA Breakthrough Device Designation. Breakthrough Device Designation is not FDA approval, clearance or marketing authorization. The device remains subject to applicable FDA regulatory review requirements, and the designation does not guarantee future FDA approval, clearance or authorization.
For more information, visit https://spotmas.com.hk
Contact:
hk***@***********ns.com
Source: Gene Solutions Hong Kong Limited.
SPOTMAS_062026_04
Hashtag: #SPOTMAS
https://spotmas.com.hk/The issuer is solely responsible for the content of this announcement.
Media OutReach
St Francis Methodist School International Shares 2023–2024 WACE Outcomes and Student Journeys
Overview of the WACE Curriculum at SFMS
SFMS International is among a small number of institutions in Singapore offering the WACE curriculum and has delivered this programme for over 23 years. The WACE is a recognised senior secondary qualification awarded by the School Curriculum and Standards Authority (SCSA) on behalf of the Ministry of Education, Western Australia. It prepares students for university admission both locally and internationally.
SFMS is also currently the only school in Singapore offering a Senior High Preparatory Pathway (WACE) for students in Years 9–10. This introduces students to the structure and expectations of the curriculum earlier, building familiarity with subject content and assessment formats before progressing to the senior years. Additionally, subject selection in Years 11A and 12A is structured to meet university entry requirements and reflect students’ academic interests.
Academic Outcomes and University Placements
In 2023, 8 out of 12 WACE graduates from SFMS International achieved ATAR scores above 90, meeting the eligibility criteria for universities such as the National University of Singapore (NUS) and Nanyang Technological University (NTU). The cohort’s top scorer, Wang Dawei, recorded an ATAR of 96.15 and enrolled at NTU to study Business and International Trading. In addition to local placements, graduates were admitted to international universities such as the University of Melbourne and Fudan University in China.
In 2024, 2 out of 8 graduates also attained ATAR scores above 90. The highest scorer, Youn Chae-Won, achieved an ATAR of 95.3. Her university placement is currently pending.
Student Journeys and Holistic Development
Students in the WACE programme at SFMS International engage in both academic and co-curricular activities as part of their overall learning experience. Recent graduates have taken part in service learning, subject specialisation, and personal reflection throughout their time in the pre-university programme.
Youn Chae-Won, the 2024 valedictorian, joined SFMS International from Korea in 2021. Over time, she adjusted to a new academic environment and explored subjects such as accounting, which influenced her interest in finance-related pathways. She also took part in various aspects of school life, including a service learning trip to Bintan in 2023, where students supported local sanitation efforts. Her involvement in both academic and co-curricular settings marked a broad engagement with school life during her time at SFMS.
Andrew Zhuang, who enrolled in SFMS International in 2019, pursued subjects such as Business Management, Accounting, and English as an Additional Language (EALD). Beyond academics, he was involved in community fundraising and joined the same Bintan service trip. He also attended weekly chapel sessions and received support from peers and teachers during a period of health-related absence.
These outcomes reflect the ongoing role of the WACE programme at SFMS International in supporting students through both academic pathways and broader educational experiences. Under the leadership of Principal Mr Lee Hak Boon, the school continues to emphasise academic planning, subject selection, and student wellbeing as part of its overall approach to pre-university education.
Hashtag: #StFrancisMethodistSchoolInternational
https://www.sfms.edu.sg/
https://www.facebook.com/sfms.singapore
https://www.instagram.com/sfms_sg/
https://www.youtube.com/channel/UC_bb9hcNhAk7WgYBE_FI61A/featured
The issuer is solely responsible for the content of this announcement.
About St Francis Methodist School International
Established in 1960, St Francis Methodist School International (SFMS) is an educational institution in Singapore that offers primary, secondary, and pre-university programmes. The school provides several academic pathways, including the International Baccalaureate (IB), Cambridge IGCSE, and the Western Australian Certificate of Education (WACE), preparing students for further studies in local and overseas institutions.
